In the initial investigative study funded by the VA Research Foundation of Oklahoma
City and Dr. Michael Bronze at the OU College of Medicine
, veterans with chronic HCV were given oral doses of Fluvastatin daily for two to 12 weeks. Within a month, half of the patients showed a reduction of the virus. One patient's viral load was about 50 times lower than before taking Fluvastatin.
Hepatitis C is a significant problem for Oklahoma.